SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Xingbo Wang who wrote (158)4/18/1997 8:26:00 AM
From: Paul Getman   of 305
 
Perhaps others have noticed this before I did, but IMUL's annual report notes that the company has stopped clinical work on both the MS drug and cocaine vaccine. Dr. Marr writes that IMUL wants to concentrate on the Allervax product line. He also seems to be saying (or hinting) that IMUL is taking steps to preserve cash since commercialization is now 3 to 4 years away and their cash won't last that long. Personally, I was surprised and disappointed to learn that IMUL has stopped work on MS and cocaine vaccine, and I wonder if in retrospect that was one of the causes of the sharp selloff we've seen.

Paul
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News